Charles River Laboratories Stock Surges 309% in Trading Volume Ranking 385th

On May 12, 2025, Charles River Laboratories International, Inc. (CRL) saw a significant surge in its stock price, rising by 3.09% to close at $138.79. The trading volume for the day was 3.36 billion, marking a 161.15% increase from the previous day. This surge in trading volume placed CRL at the 385th position in the overall stock market rankings for the day.

Charles River Laboratories International, Inc. (CRL) has recently reaffirmed its outlook for 2025, projecting revenues to be in the range of $3.30 billion to $3.45 billion and Adjusted EBITDA to be between $555 million and $605 million. This reaffirmation comes as the company continues to focus on its North American markets (NAMs) and other strategic initiatives to drive growth and profitability.

In addition to its financial outlook, Charles River Laboratories has been actively involved in various strategic initiatives. The company has been focusing on expanding its capabilities in the tumor microenvironment, a critical area of research in oncology. This focus is part of a broader strategy to enhance its offerings in the biopharmaceutical services sector, which is a key growth driver for the company.